Who is it for?

Abnormal wear and tear of the articular cartilage surfaces, known as arthrosis, is now a widespread disease. According to some estimates, this affects 15 to 20 per cent of older people. Optivisc Single™ is recommended for the symptomatic treatment of degenerative joint diseases. An Optivisc Single™ injection administered just once into the joint cavity relieves pain and improves joint mobility in the long term through its exceptional moisture-retaining and shock-absorbing properties.

Active, competitive sports and bodybuilding put extreme stress on the joints, which can lead to their cartilage surface wearing out faster. As the need for free and painless movement is of utmost importance, articular cartilage wear should be treated as quickly as possible in every case in order to maintain the possibility of pain-free movement.

Previous damage to the joint and cartilage, joint diseases or articular surgery are often implicated as triggers or predisposing factors in cartilage damage. Optivisc Single™ provides mechanical protection and acts as a lubricant.